Skip to Main Content

Paper Details

Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study.
Curr Med Res Opin
2
2020
AHAs, AP, Acute pancreatitis, T2DM, acute pancreatitis, canagliflozin, dipeptidyl peptidase-4, glucagon-like peptide-1 receptor, glucose, insulin, patients, person, sodium, sodium glucose co-transporter 2, sulfonylureas, thiazolidinediones, type 2 diabetes, type 2 diabetes mellitus

Datasets

Release 1.2